NewsRx

Search our medical news database

Sigma-Aldrich

New developments from Sigma-Aldrich outlined recently

Published in Medical Patent Week, April 29th, 2007

New developments from Sigma-Aldrich outlined recently.

This trend article is an immediate alert from NewsRx to identify the most recent news developments at Sigma-Aldrich.

Report 1: SAFC, a member of the Sigma-Aldrich Group (Nasdaq: SIAL), announced today that it has completed the initial phase of a two-stage expansion at its SAFC Pharmorphix(TM) research facility in Cambridge, U.K., for its SAFC Pharma business. Completion of a 2,500 sq. ft. laboratory extension will be followed by additional investment in spring 2007 as part of a $600,000 expansion program.

SAFC Pharmorphix is one of a few organizations specializing in solid...

Want to see the full article?

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now


Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Medical Patent Week


NewsRx is Social

Follow us on your favorite social network by clicking on a button below:

Follow NewsRx on Twitter

NewsRx on Facebook

Awards

eHealthcare Leadership 2011 Winner
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

  • Google 2010 PageRank: #2 Among Top Health News and Media Publications
  • Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
  • Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
  • Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx on Facebook